Recent attention has also been directed towards novel potential interventions, including protective gene variants such as amyloid precursor protein (APP) A673T to reduce Aβ, and Apolipoprotein E (APOE)- ε2 to reduce the risk of AD [14]. This evidence concerns the gene APP and Alzheimer disease.